33 results
DEF 14A
ALGS
Aligos Therapeutics Inc
27 Apr 21
Definitive proxy
4:15pm
Principal Accountant Fees and Services
Pre-Approval Policies and Procedures
REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS
CORPORATE GOVERNANCE …
Code of Business Conduct and Ethics
Corporate Governance Guidelines
Independence of the Board of Directors
Leadership Structure of the Board
Role
PRE 14A
ALGS
Aligos Therapeutics Inc
16 Apr 24
Preliminary proxy
5:27pm
OF AUTHORIZED SHARES OF VOTING COMMON STOCK FROM 300,000,000 TO 500,000,000
REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS
CORPORATE GOVERNANCE … ., M.D.(3)
Director
Carole Nuechterlein, J.D.(1)(3)
Director
Member of the Nominating and Corporate Governance Committee.
Member of the Audit Committee
S-1/A
EX-10.11
1ke13tvt5 ti7
9 Oct 20
IPO registration (amended)
5:26pm
8-K
ncvdg2s 0ca
27 Apr 21
Departure of Directors or Certain Officers
4:13pm
8-K
cfbqmi2978qwtilufxk3
18 Nov 21
Departure of Directors or Certain Officers
4:15pm
S-1/A
EX-3.5
rkpu4 g9k
9 Oct 20
IPO registration (amended)
5:26pm
8-K
EX-3.2
m20ez184ieoy6t3
20 Oct 20
Amendments to Articles of Incorporation or Bylaws
4:03pm
S-1/A
ep9ftjdklk ywlx8ktn6
9 Oct 20
IPO registration (amended)
5:26pm
424B4
napwqzo z4e6ws2
19 Oct 20
Prospectus supplement with pricing info
5:21pm
S-1
y5omnhkpcainz32
25 Sep 20
IPO registration
5:27pm
DRS
7rf1xr
26 Aug 20
Draft registration statement
12:00am
10-K
8f0la1e2hz pl5ol22y
23 Mar 21
Annual report
4:26pm